Published in
Taylor & Francis, Expert Opinion on Investigational Drugs, 4(12), p. 689-712
DOI: 10.1517/eoid.12.4.689.23749
Taylor & Francis, Expert Opinion on Investigational Drugs, 4(12), p. 689-712
DOI: 10.1517/13543784.12.4.689
Links
Tools
Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 